SEC Form 4/A · accession 0001209191-19-007711
HARVARD BIOSCIENCE INC · HBIO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
This is an amendment (Form 4/A). It replaces an earlier filing for the same period.
Reporting owner
James W Green
Director
Period of report
Aug 29, 2018
Accepted (ET)
Feb 6, 2019 · 4:10 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001123494
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2,F3 | Aug 29, 2018 | P | 2,500 | $5.74 | A | 159,812 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1This transaction was executed in multiple trades at prices ranging from $5.73 to $5.75. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F2Includes (a) a deferred stock award of 18,100 restricted stock units which fully vest on the earlier of (i) the date of the Issuer's next Annual Meeting of Stockholders after May 17, 2018, immediately prior to the commencement of such meeting, and (ii) May 17, 2019; (b) a deferred stock award of 11,250 restricted stock units which vest quarterly in equal installments on September 30, 2018 and December 31, 2018; and (c) 130,462 shares of common stock held by the Reporting Person.
- F3This amendment is being filed to correct an administrative error by which 5,625 shares were inadvertently omitted from this amount in the reporting person's Form 4 filed on August 30, 2018 and subsequently omitted from the Form 4 filed on January 3, 2019.
Remarks
This form has been signed under power of attorney.